Liang Han, Yu Wang, Yao Huang, Jiahui Yan, Tingting Li, Xin Ba, Weiji Lin, Ying Huang, Zhe Chen, Shenghao Tu, Kai Qin
BACKGROUND: Tumor-induced osteomalacia (TIO) is a rare, tumor-induced, metabolic bone disorder, the exact incidence of which is unknown. The most common cause of TIO is hypersecretion of tumor-derived fibroblast growth factor 23 (FGF23). Surgical resection can cure TIO in most cases, while for patients with TIO who are ineligible for surgery, biologic antibodies targeting FGF23 can be used as treatment. However, the diagnosis of TIO is more difficult than its treatment as the initial presentation can be misleading or nonspecific; thus, diagnosing TIO remains a clinical challenge...
February 28, 2023: Translational Cancer Research